Intravitreal autologous CD34+ cells ( DrugBank: - )


1 disease
告示番号疾患名(ページ内リンク)臨床試験数
90網膜色素変性症1

90. 網膜色素変性症


臨床試験数 : 147 薬物数 : 176 - (DrugBank : 43) / 標的遺伝子数 : 49 - 標的パスウェイ数 : 110
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT04925687
(ClinicalTrials.gov)
June 1, 20212/6/2021Pilot Study of Intravitreal Autologous CD34+ Stem Cell Therapy for Retinitis PigmentosaA Pilot Study of the Feasibility and Safety of Intravitreal Autologous Bone Marrow CD34+ Stem Cell Therapy for Eyes With Vision Loss From Retinitis PigmentosaRetinitis PigmentosaBiological: Intravitreal autologous CD34+ cellsUniversity of California, DavisCures Within ReachRecruiting18 YearsN/AAll4Phase 1United States